Paper35767366
Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
Casadó-Llombart S and 8 others. Prostate, 2022. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution. Papers, record 35767366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35767366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Activated-Leukocyte Cell Adhesion Molecule | Major topic |
| Prostatic Neoplasms | Major topic |
| Antigens, CD | |
| Antigens, Differentiation, T-Lymphocyte | |
| CD5 Antigens | |
| Cell Adhesion | |
| Humans | |
| Lymphocyte Activation | |
| Male | |
| T-Lymphocytes | |
| Tumor Microenvironment |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26991857 | Impact of the functional CD5 polymorphism A471V on the response of chronic lymphocytic leukaemia to conventional chemotherapy regimens. | Br J Haematol | 2017 | https://conductscience.org/library/papers/26991857 | PubMed |
| 2 | 29225340 | Genetic and experimental evidence for the involvement of the CD6 lymphocyte receptor in psoriasis. | Cell Mol Immunol | 2018 | https://conductscience.org/library/papers/29225340 | PubMed |
| 3 | 27108704 | Genetic polymorphisms of cell adhesion molecules in Behcet's disease in a Chinese Han population. | Sci Rep | 2016 | https://conductscience.org/library/papers/27108704 | PubMed |
| 4 | 33125054 | The T cell CD6 receptor operates a multitask signalosome with opposite functions in T cell activation. | J Exp Med | 2021 | https://conductscience.org/library/papers/33125054 | PubMed |
| 5 | 15532095 | Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. | J Pathol | 2005 | https://conductscience.org/library/papers/15532095 | PubMed |
| 6 | 25402503 | Analysis of ancestral and functionally relevant CD5 variants in systemic lupus erythematosus patients. | PLoS One | 2014 | https://conductscience.org/library/papers/25402503 | PubMed |
| 7 | 23128233 | Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. | Nature | 2012 | https://conductscience.org/library/papers/23128233 | PubMed |
| 8 | 24385212 | ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone. | Cancer Res | 2014 | https://conductscience.org/library/papers/24385212 | PubMed |
| 9 | 31231358 | Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment. | Front Immunol | 2019 | https://conductscience.org/library/papers/31231358 | PubMed |
| 10 | 35767366 | Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution. | Prostate | 2022 | https://conductscience.org/library/papers/35767366 | PubMed |
| 11 | 23143596 | High-density genetic mapping identifies new susceptibility loci for rheumatoid arthritis. | Nat Genet | 2012 | https://conductscience.org/library/papers/23143596 | PubMed |
| 12 | 22006014 | Prostate cancer in the elderly: frequency of advanced disease at presentation and disease-specific mortality. | Cancer | 2012 | https://conductscience.org/library/papers/22006014 | PubMed |
| 13 | 24740813 | CD166 regulates human and murine hematopoietic stem cells and the hematopoietic niche. | Blood | 2014 | https://conductscience.org/library/papers/24740813 | PubMed |
| 14 | 32630247 | Immunotherapy in Prostate Cancer. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32630247 | PubMed |
| 15 | 18519750 | Phenotypic analysis of prostate-infiltrating lymphocytes reveals TH17 and Treg skewing. | Clin Cancer Res | 2008 | https://conductscience.org/library/papers/18519750 | PubMed |
| 16 | 3344216 | A simple salting out procedure for extracting DNA from human nucleated cells. | Nucleic Acids Res | 1988 | https://conductscience.org/library/papers/3344216 | PubMed |
| 17 | 28811688 | Genetic Variation in CD166 Gene and Its Association with Bladder Cancer Risk in North Indian Population. | Indian J Clin Biochem | 2017 | https://conductscience.org/library/papers/28811688 | PubMed |
| 18 | 25108577 | Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer. | Eur Urol | 2015 | https://conductscience.org/library/papers/25108577 | PubMed |
| 19 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 20 | 18279810 | Activated leukocyte cell adhesion molecule: a new paradox in cancer. | Transl Res | 2008 | https://conductscience.org/library/papers/18279810 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36795805 | CD5 expression by dendritic cells directs T cell immunity and sustains immunotherapy responses. | Science | 2023 | https://conductscience.org/library/papers/36795805 | PubMed |
| 35767366 | Gene variation impact on prostate cancer progression: Lymphocyte modulator, activation, and cell adhesion gene variant contribution. | Prostate | 2022 | https://conductscience.org/library/papers/35767366 | PubMed |
Genes8
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ALCAM | 214 | PubTator's text mining | https://conductscience.org/library/genes/214 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD5 | 921 | PubTator's text mining | https://conductscience.org/library/genes/921 | NCBI Gene |
| CD6 | 923 | PubTator's text mining | https://conductscience.org/library/genes/923 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
| KLK3 | 354 | PubTator's text mining | https://conductscience.org/library/genes/354 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TRBV20OR9-2 | 6962 | PubTator's text mining | https://conductscience.org/library/genes/6962 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35767366
GET https://conductscience.org/api/papers/v1/35767366/references?page=2